19 results

821 Systems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response
Nikhil Kirtipal, Youngchang Seo, Jangwon Son, Sunjae Lee
KMSID: 1516088737   Diabetes Metab J. 2024;48(5):821-836.   Published online 2024 September 12    DOI: http://dx.doi.org/10.4093/dmj.2024.0382
      
837 Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
Ja Young Jeon, Dae Jung Kim
KMSID: 1516088735   Diabetes Metab J. 2024;48(5):837-846.   Published online 2024 September 12    DOI: http://dx.doi.org/10.4093/dmj.2024.0317
      
847 Artificial Light at Night and Type 2 Diabetes Mellitus
Jong-Ha Baek, Yong Zhu, Chandra L. Jackson, Yong-Moon Mark Park
KMSID: 1516088734   Diabetes Metab J. 2024;48(5):847-863.   Published online 2024 September 12    DOI: http://dx.doi.org/10.4093/dmj.2024.0237
      
864 T-Cell Senescence in Human Metabolic Diseases
Ha Thi Nga, Thi Linh Nguyen, Hyon-Seung Yi
KMSID: 1516088733   Diabetes Metab J. 2024;48(5):864-881.   Published online 2024 August 28    DOI: http://dx.doi.org/10.4093/dmj.2024.0140
      
882 Ideal Combination of Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus
Hye Soon Kim
KMSID: 1516088731   Diabetes Metab J. 2024;48(5):882-884.   Published online 2024 September 12    DOI: http://dx.doi.org/10.4093/dmj.2024.0479
      
885 Single-Cell Landscape and a Macrophage Subset Enhancing Brown Adipocyte Function in Diabetes
Junfei Gu, Jiajia Jin, Xiaoyu Ren, Xinjie Zhang, Jiaxuan Li, Xiaowei Wang, Shucui Zhang, Xianlun Yin, Qunye Zhang, Zhe Wang
KMSID: 1516088720   Diabetes Metab J. 2024;48(5):885-900.   Published online 2024 May 29    DOI: http://dx.doi.org/10.4093/dmj.2023.0278
      
901 DGAT2 Plays a Crucial Role to Control ESRRAPROX1 Transcriptional Network to Maintain Hepatic Mitochondrial Sustainability
Yoseob Lee, Yeseong Hwang, Minki Kim, Hyeonuk Jeon, Seyeon Joo, Sungsoon Fang, Jae-Woo Kim
KMSID: 1516088723   Diabetes Metab J. 2024;48(5):901-914.   Published online 2024 April 22    DOI: http://dx.doi.org/10.4093/dmj.2023.0368
      
915 Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial
Ji-Yeon Park, Joonyub Lee, Yoon-Hee Choi, Kyung Wan Min, Kyung Ah Han, Kyu Jeung Ahn, Soo Lim, Young-Hyun Kim, Chul Woo Ahn, Kyung Mook Choi, Kun-Ho Yoon
KMSID: 1516088718   Diabetes Metab J. 2024;48(5):915-928.   Published online 2024 April 23    DOI: http://dx.doi.org/10.4093/dmj.2023.0259
      
929 Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus
Shinae Kang, Yu-Bae Ahn, Tae Keun Oh, Won-Young Lee, Sung Wan Chun, Boram Bae, Amine Dahaoui, Jin Sook Jeong, Sungeun Jung, Hak Chul Jang
KMSID: 1516088719   Diabetes Metab J. 2024;48(5):929-936.   Published online 2024 February 27    DOI: http://dx.doi.org/10.4093/dmj.2023.0297
      
937 Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial
Ji Hye Heo, Kyung Ah Han, Jun Hwa Hong, Hyun-Ae Seo, Eun-Gyoung Hong, Jae Myung Yu, Hye Seung Jung, Bong-Soo Cha
KMSID: 1516088722   Diabetes Metab J. 2024;48(5):937-948.   Published online 2024 February 2    DOI: http://dx.doi.org/10.4093/dmj.2023.0314
      
949 A New Tool to Identify Pediatric Patients with Atypical Diabetes Associated with Gene Polymorphisms
Sophie Welsch, Antoine Harvengt, Paola Gallo, Manon Martin, Dominique Beckers, Thierry Mouraux, Nicole Seret, Marie-Christine Lebrethon, Raphaël Helaers, Pascal Brouillard, Miikka Vikkula, Philippe A. Lysy
KMSID: 1516088717   Diabetes Metab J. 2024;48(5):949-959.   Published online 2024 March 22    DOI: http://dx.doi.org/10.4093/dmj.2023.0166
      
960 Biologically Informed Polygenic Scores for Brain Insulin Receptor Network Are Associated with Cardiometabolic Risk Markers and Diabetes in Women
Jannica S. Selenius, Patricia P. Silveira, Mikaela von Bonsdorff, Jari Lahti, Hannu Koistinen, Riitta Koistinen, Markku Seppälä, Johan G. Eriksson, Niko S. Wasenius
KMSID: 1516088714   Diabetes Metab J. 2024;48(5):960-970.   Published online 2024 March 25    DOI: http://dx.doi.org/10.4093/dmj.2023.0039
      
971 Healthy Lifestyle and the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Large Prospective Cohort Study
Qing Chang, Yixiao Zhang, Tingjing Zhang, Zuyun Liu, Limin Cao, Qing Zhang, Li Liu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Yang Ding, Yuhong Zhao, Kaijun Niu, Yang Xia
KMSID: 1516088715   Diabetes Metab J. 2024;48(5):971-982.   Published online 2024 March 19    DOI: http://dx.doi.org/10.4093/dmj.2023.0133
      
983 Glycemic Control and Retinal Microvascular Changes in Type 2 Diabetes Mellitus Patients without Clinical Retinopathy
Kangmin Lee, Ga Hye Lee, Seung Eun Lee, Jee Myung Yang, Kunho Bae
KMSID: 1516088716   Diabetes Metab J. 2024;48(5):983-992.   Published online 2024 March 13    DOI: http://dx.doi.org/10.4093/dmj.2023.0149
      
993 Prognostic Value of Plasma Endothelin-1 in Predicting Worse Outcomes in Patients with Prediabetes and Diabetes and Stable Coronary Artery Diseases
Cheng Yang, Cheng-Gang Zhu, Yuan-Lin Guo, Na-Qiong Wu, Qian Dong, Rui-Xia Xu, Yong-Jian Wu, Jie Qian, Jian-Jun Li
KMSID: 1516088721   Diabetes Metab J. 2024;48(5):993-1002.   Published online 2024 August 21    DOI: http://dx.doi.org/10.4093/dmj.2023.0410
      
1003 Construction of Risk Prediction Model of Type 2 Diabetic Kidney Disease Based on Deep Learning (Diabetes Metab J 2024;48:771-9)
Bo Mi Seo, Jong Wook Choi
KMSID: 1516088730   Diabetes Metab J. 2024;48(5):1003-1004.   Published online 2024 September 12    DOI: http://dx.doi.org/10.4093/dmj.2024.0464
      
1005 Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64)
Eun Young Lee
KMSID: 1516088736   Diabetes Metab J. 2024;48(5):1005-1007.   Published online 2024 September 12    DOI: http://dx.doi.org/10.4093/dmj.2024.0417
      
1008 Construction of Risk Prediction Model of Type 2 Diabetic Kidney Disease Based on Deep Learning (Diabetes Metab J 2024;48:771-9)
Chuan Yun, Fangli Tang, Qingqing Lou
KMSID: 1516088732   Diabetes Metab J. 2024;48(5):1008-1011.   Published online 2024 September 12    DOI: http://dx.doi.org/10.4093/dmj.2024.0490
      
1012 Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64)
Young-Hwan Park, Minji Sohn, Soo Lim
KMSID: 1516088738   Diabetes Metab J. 2024;48(5):1012-1013.   Published online 2024 September 12    DOI: http://dx.doi.org/10.4093/dmj.2024.0485
      
Articles from Diabetes & Metabolism Journal are provided here courtesy of Korean Diabetes Association